Inventor · disambiguated record
Henri Lichenstein
Also filed as: LICHENSTEIN HENRI · LICHENSTEIN HENRI S · LICHENSTEIN HENRI STEPHEN
37 granted patents·55 pending applications·161 citations·filing 1992–2025
97Inventor score
Files withAI THERAPEUTICS INC19LAM THERAPEUTICS INC14AL THERAPEUTICS INC8SHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD7AMGEN INC6
Top patents by PatentIndex Score
92 records- 0195US11957688B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·2 cites·21 claims
- 0295US11439649B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·4 cites·21 claims
- 0393US11103449B2Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·4 cites·13 claims
- 0492US11491143B2Inhalable rapamycin formulation for the treatment of pulmonary hypertensionAI THERAPEUTICS INC·Filed 2019·Granted Nov 8, 2022·3 cites·14 claims
- 0590US10206910B2Apilimod for use in the treatment of renal cancerLAM THERAPEUTICS INC·Filed 2015·Granted Feb 19, 2019·10 cites·15 claims
- 0689US11648199B2Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·1 cites·14 claims
- 0789US10799508B2Methods for treating cancer using HSP90 inhibitorsAI THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·4 cites·12 claims
- 0889US10751345B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·5 cites·30 claims
- 0988US10765682B2Apilimod for use in the treatment of melanomaLAM THERAPEUTICS INC·Filed 2015·Granted Sep 8, 2020·4 cites·11 claims
- 1087US11266654B2Apilimod compositions and methods for using sameAI THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·2 cites·9 claims
- 1187US11123289B2Rapamycin for the treatment of lymphangioleiomyomatosisAL THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·2 cites·12 claims
- 1287US10307371B2Rapamycin for the treatment of lymphangioleiomyomatosisAI THERAPEUTICS INC·Filed 2017·Granted Jun 4, 2019·6 cites·7 claims
- 1386US10307370B2Rapamycin for the treatment of lymphangioleiomyomatosisLAM THERAPEUTICS INC·Filed 2014·Granted Jun 4, 2019·6 cites·19 claims
- 1483US2023240986A1Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1582US10350213B2Methods for treating cancer using apilimodAI THERAPEUTICS INC·Filed 2016·Granted Jul 16, 2019·4 cites·4 claims
- 1682US10179135B2Apilimod compositions and methods for using sameLAM THERAPEUTICS INC·Filed 2015·Granted Jan 15, 2019·4 cites·18 claims
- 1781US12171874B2Rapamycin for the treatment of lymphangioleiomyomatosisORPHAI THERAPEUTICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·13 claims
- 1881US2024420850A1Methods and apparatus for making biological predictions using a trained multi-modal statistical modelQUANTUM SI INC·Filed 2024·Application pending·0 cites
- 1980US10702534B2Compositions and methods relating to the radioprotective effects of apilimodLAM THERAPEUTICS INC·Filed 2018·Granted Jul 7, 2020·1 cites·19 claims
- 2080US8846873B2Antibodies directed to GPNMB and uses thereofXIAO FENG·Filed 2012·Granted Sep 30, 2014·9 cites·27 claims
- 2180US2024285524A1Inhalable rapamycin formulation for treating age-related conditionsORPHAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2276US8828392B2Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agentLICHENSTEIN HENRI·Filed 2006·Granted Sep 9, 2014·5 cites·3 claims
- 2375US11744797B2Rapamycin for the treatment of lymphangioleiomyomatosisAL THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·12 claims
- 2475US2023255944A1Inhalable rapamycin formulation for the treatment of pulmonary hypertensionAI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2574US7253266B2Polypeptides of FGF-CXCURAGEN CORP·Filed 2002·Granted Aug 7, 2007·5 cites·11 claims
- 2674US7189693B2Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptidesCURAGEN CORP·Filed 2002·Granted Mar 13, 2007·4 cites·26 claims
- 2773US10729694B2Anti-viral compositions containing PIKfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2016·Granted Aug 4, 2020·1 cites·16 claims
- 2873US7056885B1Fibroblast growth factor and nucleic acids encoding sameCURAGEN CORP·Filed 2000·Granted Jun 6, 2006·7 cites·6 claims
- 2969US11166944B2Apilimod compositions and methods for using same in the treatment of renal cancerAI Therapeutics·Filed 2019·Granted Nov 9, 2021·0 cites·11 claims
- 3066US10799469B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2019·Granted Oct 13, 2020·0 cites·2 claims
- 3165US10285959B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2014·Granted May 14, 2019·0 cites·1 claims
- 3263US5869055AAnti-inflammatory CD14 polypeptidesAMGEN INC·Filed 1995·Granted Feb 9, 1999·18 cites·14 claims
- 3362US11967436B2Methods and apparatus for making biological predictions using a trained multi-modal statistical modelQUANTUM SI INC·Filed 2019·Granted Apr 23, 2024·0 cites·20 claims
- 3461US5767243AAfamin: a human serum albumin-like proteinAMGEN INC·Filed 1997·Granted Jun 16, 1998·11 cites·10 claims
- 3561US5652352AAfamin: a human serum albumin-like geneAMGEN INC·Filed 1994·Granted Jul 29, 1997·16 cites·12 claims
- 3661US2017014341A1An Inhalable Rapamycin Formulation for Treating Age-Related ConditionsLAM THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3760US2019192525A1Apilimod compositions and methods for using sameAL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3860US2025381196A1Alpha protein kinase 1 inhibitors for use in treating kidney diseases and kidney-related diseasesSHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 3960US2024109853A1Alpha protein kinase 1 inhibitors and methods of useSHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 4059US9603926B2Histone deacetylase (HDAC) inhibitors for the treatment of cancerTOPOTARGET UK LTD·Filed 2014·Granted Mar 28, 2017·0 cites·24 claims
- 4159US2020360397A1Anti-viral compositions containing pikfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4258US2008213399A1Combination Therapies Using Hdac InhibitorsTOPOTARGET UK LTD·Filed 2006·Application pending·0 cites
- 4358US2019091229A1Therapeutic methods relating to hsp90 inhibitorsLAM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4458US2025241908A1Alpha protein kinase 1 inhibitors for use in treating atherosclerosis and related diseasesSHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 4558US2020306255A1Compositions and methods for treating niemann pick c diseaseAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4657US2020253979A1Therapeutic methods relating to hsp90 inhibitorsAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4756US2025163008A1A method for treating rosah syndromeSHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 4856US2021030759A1Method for treating cancer using hsp90 inhibitorsAL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4956US2018050041A1Compositions and Methods for Treating Niemann Pick C DiseaseLAM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5055US2024226094A1Alpha protein kinase 1 inhibitors for use in treating kawasaki diseaseSHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Henri Lichenstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →